Surgery Partners, an operator of surgical facilities and ancillary services in the US, is reportedly exploring options for a potential sale.  

The company is working with a financial adviser to assess interest from prospective buyers, Bloomberg reported, citing people with knowledge of the matter.  

Potential buyers may include private equity companies or strategic buyers. 

Sources, who requested anonymity due to the confidential nature of the talks, told Bloomberg that the discussions are still in the early stages, and Surgery Partners may decide not to proceed with a sale.  

Neither Surgery Partners nor Bain Capital, its major shareholder, have yet to publicly comment on these developments. 

Founded in 2004, the company manages over 180 locations across the US, encompassing surgery centres, physician practices, surgical hospitals, and urgent care facilities. 

The company employs more than 7,000 people and works with 4,600 affiliated physicians, providing services to approximately 600,000 patients each year. 

Surgery Partners became a publicly traded company in 2015 and expanded through a merger with National Surgical Healthcare in 2017.  

During this merger, Bain Capital took over HIG Capital's stake in the company. Bain Capital currently holds a 39% stake in Surgery Partners, according to Bloomberg's data. 

In May this year, the company forecasted that it would generate at least $3.05bn in revenue annually and a minimum of $505m in adjusted earnings before interest taxes and depreciation (EBITDA).  

Following the news of the potential sale, shares in Surgery Partners rose by 8.9% after the close of regular trading in New York on 18 July, the report added. 

Despite this surge, the company's stock has decreased in value by approximately one-third over the past year, resulting in a market valuation of $3.7bn.